SOUTH EAST ASIA AND SOUTH ASIA INDUSTRIAL MICROBIOLOGY MARKET ANALYSIS

South East Asia And South Asia Industrial Microbiology MarketSize and Trends

South East Asia and South Asia industrial microbiology market is estimated to be valued at US$ 746.1 Mn in 2023, and is expected to exhibit a CAGR of 6% during the forecast period (2023-2030).

Increasing research and development of bioproducts with clean technology by researchers is expected to drive the market growth over the forecast period. For instance, in September 2022, the Center of Excellence in Microbial Technology for Marine Pollution Treatment, Department of Microbiology, Faculty of Science, Chulalongkorn University, Thailand, started researching and developing innovative bioproducts to remove oil contaminants from the sea, aiming to expand industrial-scale production of pharmaceutical products for ecological sustainability. The researchers are focusing on developing a variety of products to create effective microbes, test production scalability, and preliminary field test for oil dispersant and degradation capacity.

South East Asia and South Asia Industrial Microbiology Market– Drivers

• Increasing product launch by market players: Increasing organic growth strategies such as product launch by key market players to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, on March 09, 2023, Vytrus Biotech, a company that specializes in active ingredients derived from plant stem cells for the cosmetic industry, launched its latest biotech active PHOTOBIOME - the microbiota photoprotector. Photobiome increased opportunities for a new category of microbial antioxidants by helping the skin microbiota to photoprotect itself by protecting and nourishing bacteria, and thus, modulating the release of its own natural photo-defense molecules that improves the signs of the photoageing process on the skin.
• Increasing inorganic growth strategies such as agreement by key market players: Increasing inorganic growth strategies such as partnership by key market players is expected to drive the market growth over the forecast period. For instance, in July 2020, Baxter, a medical device company, signed an agreement with VIPUN Medical, a biotechnology company, to commercialize the VIPUN Gastric Monitoring System. By using a smart enteral feeding tube designed to measure stomach motility, clinicians in the intensive care unit (ICU) and other settings can more accurately identify enteral feeding resistance and make decisions about nutrition therapy.

Figure 2. South East Asia and South Asia Industrial Microbiology Market Share(%), By Region, 2023

South East Asia and South Asia industrial microbiology market is segmented into product type, testing type, end user, and region.

• By product type, the market is segmented into Equipment & system (filtration pumps & systems, microbial detection systems, air monitoring systems, incubators & culture apparatus, and others), reaction consumables (media (simple media, complex media, defined media, and specialty media), reagents & stains, and others), and laboratory supply (bags & bottles, loop & needles, petrifies, racks, seals, plates & holders, sample preparation & collection, filtration discs and membranes, and others). Out of which, equipment & system is expected to hold a dominant position in the South East Asia and South Asia industrial microbiology market during the forecast period due to increasing research and development activities by key market players.
• By testing type, the market is segmented into sterility testing (open system, closed system, RTU bottles, DCM), bio-burden Ttesting (membrane, funnels), environmental testing (RTU plates, DCM, hygiene monitoring in food, air samplers, compressed gas monitoring), pyrogen testing, pathogen testing (traditional method, rapid (platform)), and others). Out of which, environmental testing is expected to dominate the market over the forecast period due to increasing growth strategies such as partnership by key market players.
• By end user, the market is segmented into pharmaceuticals & biotechnology industry, government, academia, food and beverage industry, testing labs/commercial labs, and others. Out of which, pharmaceuticals & biotechnology industry is expected to dominate the market over the forecast period due to the increasing use of microbiology instruments in pharmaceuticals & biotechnology industry.
• By region, the market is segmented into South East Asia and South Asia. Out of which, South East Asia is expected to dominate the market over the forecast period due to the increasing growth strategies such as acquisition by the key market players.
• Among all the segmentation, the product type segment is expected to dominate the market over the forecast period due to increasing investment funding by key market players to expand their product portfolio. For instance, in May 2022, Merck KGaA, a leading science and technology company, expanded its membrane and filtration manufacturing capabilities in Ireland. The company invested approximately US$ 464 Mn (€440 Mn) to increase membrane manufacturing capacity in Carrigtwohill, and in building a new manufacturing facility at Blarney Business Park, both in Cork, Ireland.